The largest community of pharma leaders

Preston W. Campbell, President and CEO of the Cystic Fibrosis Foundation to Retire; Michael P. Boyle, MD, Appointed as Successor Effective January 2020

BETHESDA, Md.–(BUSINESS WIRE)–Today the Cystic Fibrosis Foundation announced that President and CEO Preston W. Campbell, MD, plans to retire at the end of 2019. The Foundation’s Board of Trustees has selected Michael P. Boyle, MD, currently Senior Vice President, Therapeutics Development at the CF Foundation, and former director of the Johns Hopkins Adult Cystic Fibrosis Program to succeed Dr. Campbell as President and CEO. The two will work closely together during the transition period prece …

 

 

 

 

http://www.businesswire.com/news/home/20190521005806/en/Preston-W.-Campbell-President-CEO-Cystic-Fibrosis

Recent Articles

2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.